Stockreport

Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer

Natera, Inc.  (NTRA) 
Last natera, inc. earnings: 2/26 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.natera.com
PDF Multicenter, Signatera™ Genome-guided interventional trial will evaluate different treatment approaches in HR+/HER2- breast cancer AUSTIN, Texas--(BUSINESS WIRE)--Nat [Read more]